The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
KLIFS: an overhaul after the first 5 years of supporting kinase research
Open accessAbstract
Kinases are a prime target of drug development efforts with >60 drug approvals in the past two decades. Due to the research into this protein family, a wealth of data has been accumulated that keeps on growing. KLIFS—Kinase–Ligand Interaction Fingerprints and Structures—is a structural database focusing on how kinase inhibitors interact with their targets. The aim of KLIFS is to support (structure-based) kinase research through the systematic collection, annotation, and processing of kinase structures. Now, 5 years after releasing the initial KLIFS website, the database has undergone a complete overhaul with a new website, new logo, and new functionalities. In this article, we start by looking back at how KLIFS has been used by the research community, followed by a description of the renewed KLIFS, and conclude with showcasing the functionalities of KLIFS. Major changes include the integration of approved drugs and inhibitors in clinical trials, extension of the coverage to atypical kinases, and a RESTful API for programmatic access. KLIFS is available at the new domain https://klifs.net.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UniProt: a worldwide hub of protein knowledge
The UniProt Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1049 · Cited by 7,698
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201
The target landscape of clinical kinase drugs
Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P.-A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., et al. (2017) · Science · doi:10.1126/science.aan4368 · Cited by 854 · cited 1×
“(11) extensively screened nearly all clinical kinase inhibitors against hundreds of kinases and used KLIFS to classify the binding mode of these inhibitors.”
BackgroundMouse Genome Database (MGD) 2019
Bult, C. J., Blake, J. A., Smith, C. L., Kadin, J. A., Richardson, J. E., the Mouse Genome Database Group, Anagnostopoulos, A., Asabor, R., Baldarelli, R. M., Beal, J. S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1056 · Cited by 686
NGL viewer: web-based molecular graphics for large complexes
Rose, A. S., Bradley, A. R., Valasatava, Y., Duarte, J. M., Prlić, A., & Rose, P. W. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty419 · Cited by 489 · cited 2×
“The NGL viewer can, if desired, be viewed in full screen and shows both the structure residue numbering together with the KLIFS residue numbering when hovering over a residue.”
Background
Cited by
Trends in kinase drug discovery: targets, indications and inhibitor design
Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00252-y · Cited by 779
Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction
Passaro, S., Corso, G., Wohlwend, J., Reveiz, M., Thaler, S., Somnath, V. R., Getz, N., Portnoi, T., Roy, J., Stark, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.14.659707 · Cited by 665
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Roskoski, R. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107059 · Cited by 383
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
Roskoski, R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105463 · Cited by 335
Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update
Roskoski, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106552 · Cited by 273
(2024) · doi:10.1038/s41467-024-45461-2 · Cited by 243
Modeling conformational states of proteins with AlphaFold
Sala, D., Engelberger, F., Mchaourab, H. S., & Meiler, J. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102645 · Cited by 182
Kincore: a web resource for structural classification of protein kinases and their inhibitors
Modi, V., & Dunbrack, R. L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab920 · Cited by 133
Sala, D., Hildebrand, P. W., & Meiler, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1121962 · Cited by 80
mdciao: Accessible Analysis and Visualization of Molecular Dynamics Simulation Data
Pérez-Hernández, G., & Hildebrand, P. W. (2025) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1012837 · Cited by 36
From Proteins to Ligands: Decoding Deep Learning Methods for Binding Affinity Prediction
Gorantla, R., Kubincová, A., Weiße, A. Y., & Mey, A. S. J. S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01208 · Cited by 24
Dark kinase annotation, mining, and visualization using the Protein Kinase Ontology
Soleymani, S., Gravel, N., Huang, L.-C., Yeung, W., Bozorgi, E., Bendzunas, N. G., Kochut, K. J., & Kannan, N. (2023) · PeerJ · doi:10.7717/peerj.16087 · Cited by 13
Generic residue numbering of the GAIN domain of adhesion GPCRs
Seufert, F., Pérez-Hernández, G., Pándy-Szekeres, G., Guixà-González, R., Langenhan, T., Gloriam, D. E., & Hildebrand, P. W. (2025) · Nature Communications · doi:10.1038/s41467-024-55466-6 · Cited by 8
Docking-Informed Machine Learning for Kinome-wide Affinity Prediction
Schifferstein, J., Bernatavicius, A., & Janssen, A. P. A. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01260 · Cited by 8
KiSSim: Predicting Off-Targets from Structural Similarities in the Kinome
Sydow, D., Aßmann, E., Kooistra, A. J., Rippmann, F., & Volkamer, A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00050 · Cited by 6
Self-citationAll That Glitters Is Not Gold: Importance of Rigorous Evaluation of Proteochemometric Models
Avdiunina, P., Jamal, S., Gusev, F., & Isayev, O. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00395 · Cited by 4
Metadata
- Authors
- Kanev, G. K., de Graaf, C., Westerman, B. A., de Esch, I. J. P., & Kooistra, A. J.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-21
- Volume
- 49
- Issue
- D1
- Pages
- D562-D569
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W3093634533
- Cited by
- 163
- References
- 5
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.